EPISCISSORS-60™ Commercialization & Evidence Generation
Prevention of Obstetric Anal Sphincter Injuries (OASIS) during episiotomy
CommercialActive
Key Facts
Indication
Prevention of Obstetric Anal Sphincter Injuries (OASIS) during episiotomy
Phase
Commercial
Status
Active
Company
About MedInvent
MedInvent is a commercial-stage medical device company addressing a critical need in obstetrics: the precise execution of episiotomies to prevent severe perineal tears (OASIS). Its single, patented product, the EPISCISSORS-60™, is a physical guide that ensures clinicians can consistently achieve the angle recommended by global bodies like RCOG and FIGO. The device has achieved significant adoption in the UK's NHS and internationally, with multiple published studies and systematic reviews demonstrating a 50-60% relative reduction in OASIS rates, leading to substantial clinical benefits and cost savings for healthcare systems.
View full company profile